Chris Chan, PhD
See Publications

Texas Heart Institute Positions

Education

  • Postgraduate:

    Swansea University, UK (MEng)
    Swansea University, UK (PhD)

Publications

4862227 RRW6VM2M 1 alternatives-to-animal-experimentation 10 date desc Chan 53338 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%222HU94Y3J%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jing%20et%20al.%22%2C%22parsedDate%22%3A%222023-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJing%2C%20P.%2C%20Zhang%2C%20M.%2C%20%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%20et%20al.%20%282023%29.%20Diamond-like%20carbon%20films%20prepared%20by%20a%20low%20temperature%20periodic%20process%20for%20application%20in%20ventricular%20assist%20devices.%20%26lt%3Bi%26gt%3BJ%20Biomed%20Mater%20Res%20B%20Appl%20Biomater%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B111%26lt%3B%5C%2Fi%26gt%3B%2C%201048%26%23x2013%3B1058.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjbm.b.35213%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjbm.b.35213%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Diamond-like%20carbon%20films%20prepared%20by%20a%20low%20temperature%20periodic%20process%20for%20application%20in%20ventricular%20assist%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peipei%22%2C%22lastName%22%3A%22Jing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meili%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20H.%20H.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fengjuan%22%2C%22lastName%22%3A%22Jing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%20P.%22%2C%22lastName%22%3A%22Pauls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20S.%22%2C%22lastName%22%3A%22Dargusch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yongxiang%22%2C%22lastName%22%3A%22Leng%22%7D%5D%2C%22abstractNote%22%3A%22Due%20to%20the%20poor%20tribological%20properties%20of%20titanium%20%28Ti%29%20and%20its%20alloy%20Ti6Al4V%20%28commonly%20used%20for%20ventricular%20assist%20devices%20manufacturing%29%2C%20diamond-like%20carbon%20%28DLC%29%20films%20with%20excellent%20anti-wear%20properties%20are%20pursued%20to%20improve%20the%20wear%20resistance%20of%20Ti%20and%20its%20alloys.%20Considering%20the%20effect%20of%20temperature%20on%20magnets%20inside%20pump%20impellers%20and%20workpiece%20deformation%2C%20DLC%20films%20are%20preferred%20to%20be%20prepared%20under%20low%20temperature.%20In%20this%20study%2C%20DLC%20films%20were%20prepared%20on%20Ti6Al4V%20alloys%20by%20periodic%20and%20continuous%20processes%2C%20and%20the%20corresponding%20maximum%20deposition%20temperature%20was%2085%20and%20154%5Cu00b0C%2C%20respectively.%20The%20periodic%20DLC%20films%20exhibited%20the%20feature%20of%20columnar%20structure%2C%20and%20the%20surface%20hillocks%20were%20less%20uniform%20than%20that%20of%20continuous%20DLC%20films.%20The%20periodic%20DLC%20films%20possessed%20more%20sp3%20-bonded%20structures%2C%20and%20the%20accessorial%20sp3%20-bonding%20mainly%20existed%20in%20the%20form%20of%20C%5Cuf8ffH.%20Compared%20to%20continuous%20DLC%20films%2C%20the%20periodic%20DLC%20films%20had%20lower%20residual%20stress%20and%20better%20adhesion%20with%20Ti6Al4V%20substrates.%20Both%20DLC%20films%20could%20effectively%20reduce%20the%20friction%20coefficient%20and%20wear%20rate%20of%20Ti6Al4V%20alloys%20both%20in%20air%20and%20fetal%20bovine%20serum%20%28FBS%29%2C%20and%20the%20periodic%20DLC%20films%20exhibited%20superior%20anti-wear%20properties%20to%20that%20of%20continuous%20DLC%20films%20in%20FBS.%20Haemocompatibility%20evaluation%20revealed%20that%20both%20DLC%20films%20presented%20similar%20levels%20of%20more%20human%20platelet%20adhesion%20and%20activation%20as%20compared%20with%20that%20of%20bare%20Ti6Al4V.%20However%2C%20both%20DLC%20films%20significantly%20prolonged%20plasma%20clotting%20time%20in%20comparison%20to%20bare%20Ti6Al4V.%20This%20study%20demonstrates%20the%20potential%20of%20low-temperature%20DLC%20films%20as%20wear-resistant%20surface%20modification%20for%20VADs.%22%2C%22date%22%3A%222023-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjbm.b.35213%22%2C%22ISSN%22%3A%221552-4981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22T5F2AEMV%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chan%20et%20al.%22%2C%22parsedDate%22%3A%222023-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%2C%20Murashige%2C%20T.%2C%20Bieritz%2C%20S.%20A.%20et%20al.%20%282023%29.%20Mitigation%20effect%20of%20cell%20exclusion%20on%20blood%20damage%20in%20spiral%20groove%20bearings.%20%26lt%3Bi%26gt%3BJ%20Biomech%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B146%26lt%3B%5C%2Fi%26gt%3B%2C%20111394.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbiomech.2022.111394%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbiomech.2022.111394%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mitigation%20effect%20of%20cell%20exclusion%20on%20blood%20damage%20in%20spiral%20groove%20bearings%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20Hoi%20Houng%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomotaka%22%2C%22lastName%22%3A%22Murashige%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shelby%20A.%22%2C%22lastName%22%3A%22Bieritz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clayton%22%2C%22lastName%22%3A%22Semenzin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Leslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Simmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoff%20D.%22%2C%22lastName%22%3A%22Tansley%22%7D%5D%2C%22abstractNote%22%3A%22Cell%20exclusion%20in%20spiral%20groove%20bearing%20%28SGB%29%20excludes%20red%20blood%20cells%20from%20high%20shear%20regions%20in%20the%20bearing%20gaps%20and%20potentially%20reduce%20haemolysis%20in%20rotary%20blood%20pumps.%20However%2C%20this%20mechanobiological%20phenomenon%20has%20been%20observed%20in%20ultra-low%20blood%20haematocrit%20only%2C%20whether%20it%20can%20mitigate%20blood%20damage%20in%20a%20clinically-relevant%20blood%20haematocrit%20remains%20unknown.%20This%20study%20examined%20whether%20cell%20exclusion%20in%20a%20SGB%20alters%20haemolysis%20and%5C%2For%20high-molecular-weight%20von%20Willebrand%20factor%20%28HMW%20vWF%29%20multimer%20degradation.%20Citrated%20human%20blood%20was%20adjusted%20to%2035%5Cu00a0%25%20haematocrit%20and%20exposed%20to%20a%20SGB%20%28n%5Cu00a0%3D%5Cu00a06%29%20and%20grooveless%20disc%20%28n%5Cu00a0%3D%5Cu00a03%2C%20as%20a%20non-cell%20exclusion%20control%29%20incorporated%20into%20a%20custom-built%20Couette%20test%20rig%20operating%20at%202000RPM%20for%20an%20hour%3B%20shearing%20gaps%20were%2020%2C%2030%2C%20and%2040%5Cu00a0%5Cu03bcm.%20Haemolysis%20was%20assessed%20via%20spectrophotometry%20and%20HMW%20vWF%20multimer%20degradation%20was%20detected%20with%20gel%20electrophoresis%20and%20immunoblotting.%20Haemolysis%20caused%20by%20the%20SGB%20at%20gaps%20of%2020%2C%2030%20and%2040%5Cu00a0%5Cu03bcm%20were%2010.6%5Cu00a0%5Cu00b1%5Cu00a03.3%2C%209.6%5Cu00a0%5Cu00b1%5Cu00a02.7%20and%2010.5%5Cu00a0%5Cu00b1%5Cu00a03.9%5Cu00a0mg%5C%2FdL.hr%20compared%20to%2023.3%5Cu00a0%5Cu00b1%5Cu00a02.6%2C%2012.8%5Cu00a0%5Cu00b1%5Cu00a03.2%2C%209.8%5Cu00a0%5Cu00b1%5Cu00a01.8%5Cu00a0mg%5C%2FdL.hr%20by%20grooveless%20disc.%20At%20the%20same%20shearing%20gap%20of%2020%5Cu00a0%5Cu00b5m%2C%20there%20was%20a%20significant%20reduced%20in%20haemolysis%20%28P%5Cu00a0%3D%5Cu00a00.0001%29%20and%20better%20preserved%20in%20HMW%20vWF%20multimers%20%28p%5Cu00a0%26lt%3B%5Cu00a00.05%29%20when%20compared%20SGB%20to%20grooveless%20disc.%20The%20reduction%20in%20blood%20damage%20in%20the%20SGB%20compared%20to%20grooveless%20disc%20is%20indicative%20of%20cell%20exclusion%20occurred%20at%20the%20gap%20of%2020%5Cu00a0%5Cu00b5m.%20This%20is%20the%20first%20experimental%20study%20to%20demonstrate%20that%20cell%20exclusion%20in%20a%20SGB%20mitigates%20the%20shear-induced%20blood%20damage%20in%20a%20clinically-relevant%20blood%20haematocrit%20of%2035%5Cu00a0%25%2C%20which%20can%20be%20potentially%20utilised%20in%20future%20blood%20pump%20design.%22%2C%22date%22%3A%222023-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbiomech.2022.111394%22%2C%22ISSN%22%3A%221873-2380%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22LY6ZYNKI%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZhang%2C%20Y.%2C%20Zhang%2C%20M.%2C%20Xu%2C%20X.%20et%20al.%20%282022%29.%20Anti-Fouling%20Surfaces%20for%20Extracorporeal%20Membrane%20Oxygenation%20by%20Surface%20Grafting%20of%20Hydrophilic%20Sulfoxide%20Polymers.%20%26lt%3Bi%26gt%3BBiomacromolecules%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%204318%26%23x2013%3B4326.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facs.biomac.2c00775%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facs.biomac.2c00775%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anti-Fouling%20Surfaces%20for%20Extracorporeal%20Membrane%20Oxygenation%20by%20Surface%20Grafting%20of%20Hydrophilic%20Sulfoxide%20Polymers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuhao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meili%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20H.%20H.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hui%22%2C%22lastName%22%3A%22Peng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%20T.%22%2C%22lastName%22%3A%22Hill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changkui%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20K.%22%2C%22lastName%22%3A%22Whittaker%22%7D%5D%2C%22abstractNote%22%3A%22Non-thrombogenic%20surfaces%20for%20extracorporeal%20membrane%20oxygenation%20%28ECMO%29%20devices%20are%20important%20to%20increase%20their%20duration%20of%20usage%20and%20to%20enable%20long-term%20life%20support.%20However%2C%20the%20contact%20of%20blood%20with%20the%20hydrophobic%20synthetic%20ECMO%20membrane%20materials%20such%20as%20poly%284-methyl-1-pentene%29%20%28PMP%29%20can%20activate%20the%20coagulation%20cascade%2C%20causing%20thrombosis%20and%20a%20series%20of%20consequent%20complications%20during%20ECMO%20operation.%20Targeting%20this%20problem%2C%20we%20proposed%20to%20graft%20highly%20hydrophilic%20sulfoxide%20polymer%20brushes%20onto%20the%20PMP%20surfaces%20via%20gamma%20ray%20irradiation-initiated%20polymerization%20to%20improve%20the%20hemocompatibility%20of%20the%20membrane.%20Through%20this%20chemical%20modification%2C%20the%20surface%20of%20the%20PMP%20film%20is%20altered%20from%20hydrophobic%20to%20hydrophilic.%20The%20extent%20of%20plasma%20protein%20adsorption%20and%20platelet%20adhesion%2C%20the%20prerequisite%20mediators%20of%20the%20coagulation%20cascade%20and%20thrombus%20formation%2C%20are%20drastically%20reduced%20compared%20with%20those%20of%20the%20unmodified%20PMP%20film.%20Therefore%2C%20the%20method%20provides%20a%20facile%20approach%20to%20modify%20PMP%20materials%20with%20excellent%20antifouling%20properties%20and%20improved%20hemocompatibility%20demanded%20by%20the%20applications%20in%20ECMO%20and%20other%20blood-contacting%20medical%20devices.%22%2C%22date%22%3A%222022-10-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.biomac.2c00775%22%2C%22ISSN%22%3A%221526-4602%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22F4SJ2EP3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZhang%2C%20M.%2C%20%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%2C%20Pauls%2C%20J.%20P.%20et%20al.%20%282022%29.%20Investigation%20of%20heparin-loaded%20poly%28ethylene%20glycol%29-based%20hydrogels%20as%20anti-thrombogenic%20surface%20coatings%20for%20extracorporeal%20membrane%20oxygenation.%20%26lt%3Bi%26gt%3BJ%20Mater%20Chem%20B%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%204974%26%23x2013%3B4983.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1039%5C%2Fd2tb00379a%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1039%5C%2Fd2tb00379a%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Investigation%20of%20heparin-loaded%20poly%28ethylene%20glycol%29-based%20hydrogels%20as%20anti-thrombogenic%20surface%20coatings%20for%20extracorporeal%20membrane%20oxygenation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meili%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20H.%20H.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%20P.%22%2C%22lastName%22%3A%22Pauls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clayton%22%2C%22lastName%22%3A%22Semenzin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%22%2C%22lastName%22%3A%22Ainola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hui%22%2C%22lastName%22%3A%22Peng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changkui%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20K.%22%2C%22lastName%22%3A%22Whittaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silver%22%2C%22lastName%22%3A%22Heinsar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Fraser%22%7D%5D%2C%22abstractNote%22%3A%22Extracorporeal%20membrane%20oxygenation%20%28ECMO%29%2C%20a%20critical%20life-sustaining%20tool%2C%20faces%20significant%20challenges%20for%20the%20maintenance%20of%20normal%20haemostasis%20due%20to%20the%20large%20volume%20of%20circulating%20blood%20continuously%20in%20contact%20with%20artificial%20surfaces%2C%20hyperoxia%20and%20excessive%20shear%20stresses%20of%20the%20extracorporeal%20circuit.%20From%20a%20biomaterials%20perspective%2C%20it%20has%20been%20hypothesised%20that%20drug%20eluting%20coatings%20composed%20of%20haemocompatible%20hydrogels%20loaded%20with%20an%20anticoagulant%20drug%20could%20potentially%20enhance%20the%20haemocompatibility%20of%20the%20circuit.%20Poly%28ethylene%20glycol%29%20%28PEG%29%20has%20been%20well%20established%20as%20a%20biocompatible%20and%20anti-fouling%20material%20with%20wide%20biomedical%20application.%20Unfractionated%20heparin%20is%20the%20most%20commonly%20used%20anticoagulant%20for%20ECMO.%20In%20the%20present%20study%2C%20the%20feasibility%20of%20using%20heparin-loaded%20PEG-based%20hydrogels%20as%20anti-thrombogenic%20surface%20coatings%20for%20ECMO%20was%20investigated.%20The%20hydrogels%20were%20synthesised%20by%20photopolymerisation%20using%20poly%28ethylene%20glycol%29%20diacrylate%20%28PEGDA%29%20as%20the%20crosslinking%20monomer%20and%20poly%28ethylene%20glycol%29%20methacrylate%20%28PEGMA%29%20as%20the%20hydrophilic%20monomer%2C%20with%20heparin%20loaded%20into%20the%20pre-gel%20solution.%20Factors%20which%20could%20affect%20the%20release%20of%20heparin%20were%20investigated%2C%20including%20the%20ratio%20of%20PEGDA%5C%2FPEGMA%2C%20water%20content%2C%20loading%20level%20of%20heparin%20and%20the%20flow%20of%20fluid%20past%20the%20hydrogel.%20Our%20results%20showed%20that%20increased%20crosslinker%20content%20and%20decreased%20water%20content%20led%20to%20slower%20heparin%20release.%20The%20hydrogels%20with%20water%20contents%20of%2060%20wt%25%20and%2070%20wt%25%20could%20achieve%20a%20sustained%20heparin%20release%20by%20adjusting%20the%20ratio%20of%20PEGDA%5C%2FPEGMA.%20The%20anticoagulation%20efficacy%20of%20the%20released%20heparin%20was%20evaluated%20by%20measuring%20the%20activated%20clotting%20time%20of%20whole%20blood.%20The%20hydrogels%20with%20desirable%20heparin%20release%20profiles%20were%20prepared%20onto%20poly%284-methyl-1-pentene%29%20%28PMP%29%20films%20with%20the%20same%20chemical%20composition%20as%20the%20PMP%20ECMO%20membranes.%20The%20coatings%20showed%20sustained%20heparin%20release%20with%20a%20cumulative%20release%20of%2070-80%25%20after%207%20days.%20Haemocompatibility%20tests%20demonstrated%20that%20PEG%20hydrogel%20coatings%20significantly%20reduced%20platelet%20adhesion%20and%20prolonged%20plasma%20recalcification%20time.%20These%20results%20suggest%20that%20heparin-loaded%20PEG%20hydrogels%20are%20potential%20anti-thrombogenic%20coatings%20for%20ECMO.%22%2C%22date%22%3A%222022-07-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1039%5C%2Fd2tb00379a%22%2C%22ISSN%22%3A%222050-7518%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22KY543SN6%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chan%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%2C%20Simmonds%2C%20M.%20J.%2C%20Fraser%2C%20K.%20H.%20et%20al.%20%282022%29.%20Discrete%20responses%20of%20erythrocytes%2C%20platelets%2C%20and%20von%20Willebrand%20factor%20to%20shear.%20%26lt%3Bi%26gt%3BJ%20Biomech%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B130%26lt%3B%5C%2Fi%26gt%3B%2C%20110898.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbiomech.2021.110898%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbiomech.2021.110898%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discrete%20responses%20of%20erythrocytes%2C%20platelets%2C%20and%20von%20Willebrand%20factor%20to%20shear%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20H.%20H.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Simmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharine%20H.%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kosuke%22%2C%22lastName%22%3A%22Igarashi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrina%20K.%22%2C%22lastName%22%3A%22Ki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomotaka%22%2C%22lastName%22%3A%22Murashige%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20T.%22%2C%22lastName%22%3A%22Joseph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoff%20D.%22%2C%22lastName%22%3A%22Tansley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nobuo%22%2C%22lastName%22%3A%22Watanabe%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20decades%20of%20technological%20advancements%20in%20blood-contacting%20medical%20devices%2C%20complications%20related%20to%20shear%20flow-induced%20blood%20trauma%20are%20still%20frequently%20observed%20in%20clinic.%20Blood%20trauma%20includes%20haemolysis%2C%20platelet%20activation%2C%20and%20degradation%20of%20High%20Molecular%20Weight%20von%20Willebrand%20Factor%20%28HMW%20vWF%29%20multimers%2C%20all%20of%20which%20are%20dependent%20on%20the%20exposure%20time%20and%20magnitude%20of%20shear%20stress.%20Specifically%2C%20accumulating%20evidence%20supports%20that%20when%20blood%20is%20exposed%20to%20shear%20stresses%20above%20a%20certain%20threshold%2C%20blood%20trauma%20ensues%3B%20however%2C%20it%20remains%20unclear%20how%20various%20constituents%20of%20blood%20are%20affected%20by%20discrete%20shears%20experimentally.%20The%20aim%20of%20this%20study%20was%20to%20expose%20blood%20to%20discrete%20shear%20stresses%20and%20evaluate%20blood%20trauma%20indices%20that%20reflect%20red%20cell%2C%20platelet%2C%20and%20vWF%20structure.%20Citrated%20human%20whole%20blood%20%28n%5Cu00a0%3D%5Cu00a06%29%20was%20collected%20and%20its%20haematocrit%20was%20adjusted%20to%2030%5Cu00a0%5Cu00b1%5Cu00a02%25%20by%20adding%20either%20phosphate%20buffered%20saline%20%28PBS%29%20or%20polyvinylpyrrolidone%20%28PVP%29.%20Viscosity%20of%20whole%20blood%20was%20adjusted%20to%203.0%2C%2012.5%2C%2022.5%20and%2037.5%5Cu00a0mPa%5Cu00b7s%20to%20yield%20stresses%20of%203%2C%206%2C%209%2C%2012%2C%2050%2C%2090%20and%20150%5Cu00a0Pa%20in%20a%20custom-developed%20shearing%20system.%20Blood%20samples%20were%20exposed%20to%20shear%20for%200%2C%20300%2C%20600%20and%20900%5Cu00a0s.%20Haemolysis%20was%20measured%20using%20spectrophotometry%2C%20platelet%20activation%20using%20flow%20cytometry%2C%20and%20HMW%20vWF%20multimer%20degradation%20was%20quantified%20with%20gel%20electrophoresis%20and%20immunoblotting.%20For%20tolerance%20to%20300%2C%20600%20and%20900%5Cu00a0s%20of%20exposure%20time%2C%20the%20critical%20threshold%20of%20haemolysis%20was%20reached%20after%20blood%20was%20exposed%20to%2090%5Cu00a0Pa%20for%20600%5Cu00a0s%20%28P%5Cu00a0%26lt%3B%5Cu00a00.05%29%2C%20platelet%20activation%20and%20HMW%20vWF%20multimer%20degradation%20were%2050%5Cu00a0Pa%20for%20600%5Cu00a0s%20and%2012%5Cu00a0Pa%20for%20300%5Cu00a0s%20respectively%20%28P%5Cu00a0%26lt%3B%5Cu00a00.05%29.%20Our%20experimental%20results%20provide%20simultaneous%20comparison%20of%20blood%20trauma%20indices%20and%20thus%20also%20the%20relation%20between%20shear%20duration%20and%20magnitude%20required%20to%20induce%20damage%20to%20red%20cells%2C%20platelets%2C%20and%20vWF.%20Our%20results%20also%20demonstrate%20that%20near-physiological%20shear%20stress%20%28%26lt%3B12%5Cu00a0Pa%29%20is%20needed%20in%20order%20to%20completely%20avoid%20any%20form%20of%20blood%20trauma.%20Therefore%2C%20there%20is%20an%20urgent%20need%20to%20design%20low%20shear-flow%20medical%20devices%20in%20order%20to%20avoid%20blood%20trauma%20in%20this%20blood-contacting%20medical%20device%20field.%22%2C%22date%22%3A%222022-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbiomech.2021.110898%22%2C%22ISSN%22%3A%221873-2380%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22KVDPSX5D%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZhang%2C%20M.%2C%20Pauls%2C%20J.%20P.%2C%20Bartnikowski%2C%20N.%20et%20al.%20%282021%29.%20Anti-thrombogenic%20Surface%20Coatings%20for%20Extracorporeal%20Membrane%20Oxygenation%3A%20A%20Narrative%20Review.%20%26lt%3Bi%26gt%3BACS%20Biomater%20Sci%20Eng%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%2C%204402%26%23x2013%3B4419.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facsbiomaterials.1c00758%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facsbiomaterials.1c00758%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anti-thrombogenic%20Surface%20Coatings%20for%20Extracorporeal%20Membrane%20Oxygenation%3A%20A%20Narrative%20Review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meili%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%20P.%22%2C%22lastName%22%3A%22Pauls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Bartnikowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Haymet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20H.%20H.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacky%20Y.%22%2C%22lastName%22%3A%22Suen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bailey%22%2C%22lastName%22%3A%22Schneider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrina%20K.%22%2C%22lastName%22%3A%22Ki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20K.%22%2C%22lastName%22%3A%22Whittaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20S.%22%2C%22lastName%22%3A%22Dargusch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Fraser%22%7D%5D%2C%22abstractNote%22%3A%22Extracorporeal%20membrane%20oxygenation%20%28ECMO%29%20is%20used%20in%20critical%20care%20to%20manage%20patients%20with%20severe%20respiratory%20and%20cardiac%20failure.%20ECMO%20brings%20blood%20from%20a%20critically%20ill%20patient%20into%20contact%20with%20a%20non-endothelialized%20circuit%20which%20can%20cause%20clotting%20and%20bleeding%20simultaneously%20in%20this%20population.%20Continuous%20systemic%20anticoagulation%20is%20needed%20during%20ECMO.%20The%20membrane%20oxygenator%2C%20which%20is%20a%20critical%20component%20of%20the%20extracorporeal%20circuit%2C%20is%20prone%20to%20significant%20thrombus%20formation%20due%20to%20its%20large%20surface%20area%20and%20areas%20of%20low%2C%20turbulent%2C%20and%20stagnant%20flow.%20Various%20surface%20coatings%2C%20including%20but%20not%20limited%20to%20heparin%2C%20albumin%2C%20poly%28ethylene%20glycol%29%2C%20phosphorylcholine%2C%20and%20poly%282-methoxyethyl%20acrylate%29%2C%20have%20been%20developed%20to%20reduce%20thrombus%20formation%20during%20ECMO.%20The%20present%20work%20provides%20an%20up-to-date%20overview%20of%20anti-thrombogenic%20surface%20coatings%20for%20ECMO%2C%20including%20both%20commercial%20coatings%20and%20those%20under%20development.%20The%20focus%20is%20placed%20on%20the%20coatings%20being%20developed%20for%20oxygenators.%20Overall%2C%20zwitterionic%20polymer%20coatings%2C%20nitric%20oxide%20%28NO%29-releasing%20coatings%2C%20and%20lubricant-infused%20coatings%20have%20attracted%20more%20attention%20than%20other%20coatings%20and%20showed%20some%20improvement%20in%20in%20vitro%20and%20in%20vivo%20anti-thrombogenic%20effects.%20However%2C%20most%20studies%20lacked%20standard%20hemocompatibility%20assessment%20and%20comparison%20studies%20with%20current%20clinically%20used%20coatings%2C%20either%20heparin%20coatings%20or%20nonheparin%20coatings.%20Moreover%2C%20this%20review%20identifies%20that%20further%20investigation%20on%20the%20thrombo-resistance%2C%20stability%20and%20durability%20of%20coatings%20under%20rated%20flow%20conditions%20and%20the%20effects%20of%20coatings%20on%20the%20function%20of%20oxygenators%20%28pressure%20drop%20and%20gas%20transfer%29%20are%20needed.%20Therefore%2C%20extensive%20further%20development%20is%20required%20before%20these%20new%20coatings%20can%20be%20used%20in%20the%20clinic.%22%2C%22date%22%3A%222021-09-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facsbiomaterials.1c00758%22%2C%22ISSN%22%3A%222373-9878%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22QEY2ANIV%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuck%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKuck%2C%20L.%2C%20Simmonds%2C%20M.%20J.%2C%20%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%20et%20al.%20%282021%29.%20Ex%20vivo%20assessment%20of%20erythrocyte%20tolerance%20to%20the%20HeartWare%20ventricular%20assist%20device%20operated%20in%20three%20discrete%20configurations.%20%26lt%3Bi%26gt%3BArtif%20Organs%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B45%26lt%3B%5C%2Fi%26gt%3B%2C%20E146%26%23x2013%3BE157.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faor.13877%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faor.13877%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ex%20vivo%20assessment%20of%20erythrocyte%20tolerance%20to%20the%20HeartWare%20ventricular%20assist%20device%20operated%20in%20three%20discrete%20configurations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lennart%22%2C%22lastName%22%3A%22Kuck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Simmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20Hoi%20Houng%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%20P.%22%2C%22lastName%22%3A%22Pauls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoff%20D.%22%2C%22lastName%22%3A%22Tansley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friederike%22%2C%22lastName%22%3A%22Feldmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antony%20P.%22%2C%22lastName%22%3A%22McNamee%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20technological%20advances%20in%20ventricular%20assist%20devices%20%28VADs%29%20to%20treat%20end-stage%20heart%20failure%2C%20hemocompatibility%20remains%20a%20constant%20concern%2C%20with%20supraphysiological%20shear%20stresses%20an%20unavoidable%20reality%20with%20clinical%20use.%20Given%20that%20impeller%20rotational%20speed%20is%20related%20to%20the%20instantaneous%20shear%20within%20the%20pump%20housing%2C%20it%20is%20plausible%20that%20the%20modulation%20of%20pump%20speed%20may%20regulate%20peak%20mechanical%20shear%20stresses%20and%20thus%20ameliorate%20blood%20damage.%20The%20present%20study%20investigated%20the%20hemocompatibility%20of%20the%20HeartWare%20HVAD%20in%20three%20configurations%20typical%20of%20clinical%20applications%3A%20standard%20systemic%20support%20left%20VAD%20%28LVAD%29%2C%20pediatric%20support%20LVAD%2C%20and%20pulmonary%20support%20right%20VAD%20%28RVAD%29%20conditions.%20Two%20ex%20vivo%20mock%20circulation%20blood%20loops%20were%20constructed%20using%20explanted%20HVADs%2C%20in%20which%20pump%20speed%20and%20external%20loop%20resistance%20were%20manipulated%20to%20reflect%20the%20flow%20rates%20and%20differential%20pressures%20reported%20in%20configurations%20for%20standard%20adult%20LVAD%20%28at%203150%5Cu00a0rev%5Cu2e31min-1%20%29%2C%20pediatric%20LVAD%20%28at%202400%20rev%5Cu2e31min-1%20%29%2C%20and%20adult%20RVAD%20%28at%201900%20rev%5Cu2e31min-1%20%29.%20Using%20bovine%20blood%2C%20the%20mock%20circulation%20blood%20loops%20were%20tested%20at%2037%5Cu00b0C%20over%20a%20period%20of%206%5Cu00a0hours%20%28consistent%20with%20ASTM%20F1841-97%29%20and%20compared%20with%20static%20control.%20Hemocompatibility%20assessments%20were%20conducted%20for%20each%20test%20condition%2C%20examining%20hematology%2C%20hemolysis%20%28absolute%20and%20normalized%20index%29%2C%20osmotic%20fragility%2C%20and%20blood%20viscosity.%20Regardless%20of%20configuration%2C%20continuous%20exposure%20of%20blood%20to%20the%20VAD%20over%20the%206-hour%20period%20significantly%20altered%20hematological%20and%20rheological%20blood%20parameters%2C%20and%20induced%20increased%20hemolysis%20when%20compared%20with%20a%20static%20control%20sample.%20Comparison%20of%20the%20three%20operational%20VAD%20configurations%20identified%20that%20the%20adult%20LVAD%20condition-associated%20with%20the%20highest%20pump%20speed%2C%20flow%20rate%2C%20and%20differential%20pressure%20across%20the%20pump-resulted%20in%20increased%20normalized%20hemolysis%20index%20%28NIH%3B%200.07%29%20when%20compared%20with%20the%20lower%20pump%20speed%20%26quot%3Boff-label%26quot%3B%20counterparts%20%28NIH%20of%200.04%20in%20pediatric%20LVAD%20and%200.01%20in%20adult%20RVAD%20configurations%29.%20After%20normalizing%20blood%20residence%20times%20between%20configurations%2C%20pump%20speed%20was%20identified%20as%20the%20primary%20determinant%20of%20accumulated%20blood%20damage%3B%20plausibly%2C%20blood%20damage%20could%20be%20limited%20by%20restricting%20pump%20speed%20to%20the%20minimum%20required%20to%20support%20matched%20cardiac%20output%2C%20but%20not%20beyond.%22%2C%22date%22%3A%222021-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Faor.13877%22%2C%22ISSN%22%3A%221525-1594%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22XMU3CB5Y%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chan%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%2C%20Ki%2C%20K.%20K.%2C%20Zhang%2C%20M.%20et%20al.%20%282021%29.%20Extracorporeal%20Membrane%20Oxygenation-Induced%20Hemolysis%3A%20An%20In%20Vitro%20Study%20to%20Appraise%20Causative%20Factors.%20%26lt%3Bi%26gt%3BMembranes%20%28Basel%29%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20313.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fmembranes11050313%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fmembranes11050313%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extracorporeal%20Membrane%20Oxygenation-Induced%20Hemolysis%3A%20An%20In%20Vitro%20Study%20to%20Appraise%20Causative%20Factors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20Hoi%20Houng%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrina%20K.%22%2C%22lastName%22%3A%22Ki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meili%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cooper%22%2C%22lastName%22%3A%22Asnicar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hwa%20Jin%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%22%2C%22lastName%22%3A%22Ainola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahe%22%2C%22lastName%22%3A%22Bouquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silver%22%2C%22lastName%22%3A%22Heinsar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%20Philipp%22%2C%22lastName%22%3A%22Pauls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gianluigi%22%2C%22lastName%22%3A%22Li%20Bassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacky%22%2C%22lastName%22%3A%22Suen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Fraser%22%7D%5D%2C%22abstractNote%22%3A%22In%20vitro%20hemolysis%20testing%20is%20commonly%20used%20to%20determine%20hemocompatibility%20of%20ExtraCorporeal%20Membrane%20Oxygenation%20%28ECMO%29.%20However%2C%20poor%20reproducibility%20remains%20a%20challenging%20problem%2C%20due%20to%20several%20unidentified%20influencing%20factors.%20The%20present%20study%20investigated%20potential%20factors%2C%20such%20as%20flow%20rates%2C%20the%20use%20of%20anticoagulants%2C%20and%20gender%20of%20blood%20donors%2C%20which%20could%20play%20a%20role%20in%20hemolysis.%20Fresh%20human%20whole%20blood%20was%20anticoagulated%20with%20either%20citrate%20%28n%20%3D%206%29%20or%20heparin%20%28n%20%3D%2012%3B%206%20female%20and%206%20male%20blood%20donors%29.%20Blood%20was%20then%20circulated%20for%20360%20min%20at%204%20L%5C%2Fmin%20or%201.5%20L%5C%2Fmin.%20Regardless%20of%20flow%20rate%20conditions%2C%20hemolysis%20remained%20unchanged%20over%20time%20in%20citrated%20blood%2C%20but%20significantly%20increased%20after%20240%20min%20circulation%20in%20heparinized%20blood%20%28p%20%5Cu2264%200.01%29.%20The%20ratio%20of%20the%20normalized%20index%20of%20hemolysis%20%28NIH%29%20of%20heparinized%20blood%20to%20citrated%20blood%20was%2011.7-fold%20higher%20at%204%20L%5C%2Fmin%20and%2016.5-fold%20higher%20at%201.5%20L%5C%2Fmin.%20The%20difference%20in%20hemolysis%20between%201.5%20L%5C%2Fmin%20and%204%20L%5C%2Fmin%20concurred%20with%20findings%20of%20previous%20literature.%20In%20addition%2C%20the%20ratio%20of%20NIH%20of%20male%20heparinized%20blood%20to%20female%20was%201.7-fold%20higher%20at%204%20L%5C%2Fmin%20and%202.2-fold%20higher%20at%201.5%20L%5C%2Fmin.%20Our%20preliminary%20results%20suggested%20that%20the%20choice%20of%20anticoagulant%20and%20blood%20donor%20gender%20could%20be%20critical%20factors%20in%20hemolysis%20studies%2C%20and%20should%20be%20taken%20into%20account%20to%20improve%20testing%20reliability%20during%20ECMO.%22%2C%22date%22%3A%222021-04-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fmembranes11050313%22%2C%22ISSN%22%3A%222077-0375%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22WGHX5HVE%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chan%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%2C%20Ki%2C%20K.%20K.%2C%20Chu%2C%20I.%20Y.%20et%20al.%20%282021%29.%20In%20vitro%20Hemocompatibility%20Evaluation%20of%20the%20HeartWare%20Ventricular%20Assist%20Device%20Under%20Systemic%2C%20Pediatric%20and%20Pulmonary%20Support%20Conditions.%20%26lt%3Bi%26gt%3BASAIO%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B67%26lt%3B%5C%2Fi%26gt%3B%2C%20270%26%23x2013%3B275.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001222%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001222%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22In%20vitro%20Hemocompatibility%20Evaluation%20of%20the%20HeartWare%20Ventricular%20Assist%20Device%20Under%20Systemic%2C%20Pediatric%20and%20Pulmonary%20Support%20Conditions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20H.%20H.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrina%20K.%22%2C%22lastName%22%3A%22Ki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20Y.%22%2C%22lastName%22%3A%22Chu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Rolls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasha%22%2C%22lastName%22%3A%22Morris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Talvin%20J.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Bindorfer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%20P.%22%2C%22lastName%22%3A%22Pauls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iki%22%2C%22lastName%22%3A%22Idachi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Fraser%22%7D%5D%2C%22abstractNote%22%3A%22The%20development%20of%20adult%20use%20right%20ventricular%20assist%20devices%20%28RVADs%29%20and%20pediatric%20left%20ventricular%20assist%20devices%20%28pediatric%20LVADs%29%20have%20significantly%20lagged%20behind%20compared%20to%20adult%20use%20left%20ventricular%20assist%20devices%20%28LVADs%29.%20The%20HeartWare%20ventricular%20assist%20device%20%28HVAD%29%20intended%20to%20be%20used%20for%20adult%26%23039%3Bs%20systemic%20support%2C%20is%20increasingly%20used%20off-label%20for%20adult%20pulmonary%20and%20pediatric%20systemic%20support.%20Due%20to%20different%20hemodynamics%20and%20physiology%2C%20however%2C%20the%20HVAD%26%23039%3Bs%20hemocompatibility%20profiles%20can%20be%20drastically%20different%20when%20used%20in%20adult%20pulmonary%20circulation%20or%20in%20children%2C%20compared%20to%20its%20intended%20usage%20state%2C%20which%20could%20have%20a%20direct%20clinical%20and%20developmental%20relevance.%20Taking%20these%20considerations%20in%20mind%2C%20we%20sought%20to%20conduct%20in%20vitro%20hemocompatibility%20testing%20of%20HVAD%20in%20adult%20systemic%2C%20pediatric%20systemic%20and%20adult%20pulmonary%20support%20conditions.%20Two%20HVADs%20coupled%20to%20custom-built%20blood%20circulation%20loops%20were%20tested%20for%206%20hours%20using%20bovine%20blood%20at%2037%5Cu00b0C%20under%20adult%20systemic%2C%20pediatric%20systemic%2C%20and%20adult%20pulmonary%20flow%20conditions%20%28flow%20rate%20%3D%205.0%2C%202.5%2C%20and%204.5%5Cu2009L%5C%2Fmin%3B%20differential%20pressure%20%3D%20100%2C%2069%2C%20and%2020%5Cu2009mm%20Hg%2C%20respectively%29.%20Normalized%20index%20of%20hemolysis%20for%20adult%20systemic%2C%20pediatric%20systemic%2C%20and%20adult%20pulmonary%20conditions%20were%200.0083%2C%200.0039%2C%20and%200.0017%5Cu2009g%5C%2F100%5Cu2009L%2C%20respectively.%20No%20significant%20difference%20was%20seen%20in%20platelet%20activation%20for%20these%20given%20conditions.%20High%20molecular%20weight%20von%20Willebrand%20factor%20multimer%20degradation%20was%20evident%20in%20all%20conditions%20%28p%20%26lt%3B%200.05%29.%20In%20conclusion%2C%20alterations%20in%20the%20usage%20mode%20produce%20substantial%20differences%20in%20hemocompatibility%20of%20the%20HVAD.%20These%20findings%20would%20not%20only%20have%20clinical%20relevance%20but%20will%20also%20facilitate%20future%20adult%20use%20RVAD%20and%20pediatric%20LVAD%20development.%22%2C%22date%22%3A%222021-03-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMAT.0000000000001222%22%2C%22ISSN%22%3A%221538-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22TBU247RH%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chan%20et%20al.%22%2C%22parsedDate%22%3A%222020-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.%20H.%20H.%2C%20Inoue%2C%20M.%2C%20Ki%2C%20K.%20K.%20et%20al.%20%282020%29.%20Shear-dependent%20platelet%20aggregation%20size.%20%26lt%3Bi%26gt%3BArtif%20Organs%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B44%26lt%3B%5C%2Fi%26gt%3B%2C%201286%26%23x2013%3B1295.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faor.13783%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faor.13783%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Shear-dependent%20platelet%20aggregation%20size%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20Hoi%20Houng%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masataka%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrina%20K.%22%2C%22lastName%22%3A%22Ki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomotaka%22%2C%22lastName%22%3A%22Murashige%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Simmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoff%20D.%22%2C%22lastName%22%3A%22Tansley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nobuo%22%2C%22lastName%22%3A%22Watanabe%22%7D%5D%2C%22abstractNote%22%3A%22Nonsurgical%20bleeding%20is%20the%20most%20frequent%20complication%20of%20left%20ventricular%20assist%20device%20%28LVAD%29%20support.%20Supraphysiologic%20shear%20rates%20generated%20in%20LVAD%20causes%20impaired%20platelet%20aggregation%2C%20which%20increases%20the%20risk%20of%20bleeding.%20The%20effect%20of%20shear%20rate%20on%20the%20formation%20size%20of%20platelet%20aggregates%20has%20never%20been%20reported%20experimentally%2C%20although%20platelet%20aggregation%20size%20can%20be%20considered%20to%20be%20directly%20relevant%20to%20bleeding%20complications.%20Therefore%2C%20this%20study%20investigated%20the%20impact%20of%20shear%20rate%20and%20exposure%20time%20on%20the%20formation%20size%20of%20platelet%20aggregates%2C%20which%20is%20vital%20in%20predicting%20bleeding%20in%20patients%20with%20an%20LVAD.%20Human%20platelet-poor%20plasma%20%28containing%20von%20Willebrand%20factor%2C%20vWF%29%20and%20fluorochrome-labeled%20platelets%20were%20subjected%20to%20a%20range%20of%20shear%20rates%20%280-10%5Cu00a0000%5Cu00a0s-1%20%29%20for%200%2C%205%2C%2010%2C%20and%2015%5Cu00a0minutes%20using%20a%20custom-built%20blood-shearing%20device.%20Formed%20sizes%20of%20platelet%20aggregates%20under%20a%20range%20of%20shear-controlled%20environment%20were%20visualized%20and%20measured%20using%20microscopy.%20The%20loss%20of%20high%20molecular%20weight%20%28HMW%29%20vWF%20multimers%20was%20quantified%20using%20gel%20electrophoresis%20and%20immunoblotting.%20An%20inhibition%20study%20was%20also%20performed%20to%20investigate%20the%20reduction%20in%20platelet%20aggregation%20size%20and%20HMW%20vWF%20multimers%20caused%20by%20either%20mechanical%20shear%20or%20enzymatic%20%28a%20disintegrin%20and%20metalloproteinase%20with%20a%20thrombospondin%20type%201%20motif%2C%20member%2013-ADAMTS13%2C%20the%20von%20Willebrand%20factor%20protease%29%20mechanism%20under%20low%20and%20high%20shear%20conditions%20%28360%20and%2010%5Cu00a0000%5Cu00a0s-1%20%29.%20We%20found%20that%20the%20average%20size%20of%20platelet%20aggregates%20formed%20under%20physiological%20shear%20rates%20of%20360-3000%5Cu00a0s-1%20%28200-300%5Cu00a0%5Cu03bcm2%20%29%20was%20significantly%20larger%20compared%20to%20those%20sheared%20at%20%26gt%3B6000%5Cu00a0s-1%20%2850-100%5Cu00a0%5Cu03bcm2%20%29.%20Furthermore%2C%20HMW%20vWF%20multimers%20were%20reduced%20with%20increased%20shear%20rates.%20The%20inhibition%20study%20revealed%20that%20the%20reduction%20in%20platelet%20aggregation%20size%20and%20HWM%20vWF%20multimers%20were%20mainly%20associated%20with%20ADAMTS13.%20In%20conclusion%2C%20the%20threshold%20of%20shear%20rate%20must%20not%20exceed%20%26gt%3B6000%5Cu00a0s-1%20in%20order%20to%20maintain%20the%20optimal%20size%20of%20platelet%20aggregates%20to%20%26quot%3Bplug%20off%26quot%3B%20the%20injury%20site%20and%20stop%20bleeding.%22%2C%22date%22%3A%222020-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Faor.13783%22%2C%22ISSN%22%3A%221525-1594%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22RRW6VM2M%22%5D%2C%22dateModified%22%3A%222023-07-12T16%3A03%3A26Z%22%7D%7D%5D%7D
Jing, P., Zhang, M., Chan, C. H. H. et al. (2023). Diamond-like carbon films prepared by a low temperature periodic process for application in ventricular assist devices. J Biomed Mater Res B Appl Biomater 111, 1048–1058. https://doi.org/10.1002/jbm.b.35213.
Chan, C. H. H., Murashige, T., Bieritz, S. A. et al. (2023). Mitigation effect of cell exclusion on blood damage in spiral groove bearings. J Biomech 146, 111394. https://doi.org/10.1016/j.jbiomech.2022.111394.
Zhang, Y., Zhang, M., Xu, X. et al. (2022). Anti-Fouling Surfaces for Extracorporeal Membrane Oxygenation by Surface Grafting of Hydrophilic Sulfoxide Polymers. Biomacromolecules 23, 4318–4326. https://doi.org/10.1021/acs.biomac.2c00775.
Zhang, M., Chan, C. H. H., Pauls, J. P. et al. (2022). Investigation of heparin-loaded poly(ethylene glycol)-based hydrogels as anti-thrombogenic surface coatings for extracorporeal membrane oxygenation. J Mater Chem B 10, 4974–4983. https://doi.org/10.1039/d2tb00379a.
Chan, C. H. H., Simmonds, M. J., Fraser, K. H. et al. (2022). Discrete responses of erythrocytes, platelets, and von Willebrand factor to shear. J Biomech 130, 110898. https://doi.org/10.1016/j.jbiomech.2021.110898.
Zhang, M., Pauls, J. P., Bartnikowski, N. et al. (2021). Anti-thrombogenic Surface Coatings for Extracorporeal Membrane Oxygenation: A Narrative Review. ACS Biomater Sci Eng 7, 4402–4419. https://doi.org/10.1021/acsbiomaterials.1c00758.
Kuck, L., Simmonds, M. J., Chan, C. H. H. et al. (2021). Ex vivo assessment of erythrocyte tolerance to the HeartWare ventricular assist device operated in three discrete configurations. Artif Organs 45, E146–E157. https://doi.org/10.1111/aor.13877.
Chan, C. H. H., Ki, K. K., Zhang, M. et al. (2021). Extracorporeal Membrane Oxygenation-Induced Hemolysis: An In Vitro Study to Appraise Causative Factors. Membranes (Basel) 11, 313. https://doi.org/10.3390/membranes11050313.
Chan, C. H. H., Ki, K. K., Chu, I. Y. et al. (2021). In vitro Hemocompatibility Evaluation of the HeartWare Ventricular Assist Device Under Systemic, Pediatric and Pulmonary Support Conditions. ASAIO J 67, 270–275. https://doi.org/10.1097/MAT.0000000000001222.
Chan, C. H. H., Inoue, M., Ki, K. K. et al. (2020). Shear-dependent platelet aggregation size. Artif Organs 44, 1286–1295. https://doi.org/10.1111/aor.13783.